litlas
Log inCreate account

Howard Colman

Active 1990–2025

84
Papers
25,137
Citations
59
h-index
82
i10-index

Citations

Citations per year for Howard Colman1961: 1 citations1986: 1 citations1990: 1 citations1992: 1 citations1994: 4 citations1995: 3 citations1997: 6 citations1998: 16 citations1999: 8 citations2000: 7 citations2001: 13 citations2002: 12 citations2003: 22 citations2004: 14 citations2005: 26 citations2006: 51 citations2007: 62 citations2008: 79 citations2009: 110 citations2010: 172 citations2011: 186 citations2012: 237 citations2013: 241 citations2014: 263 citations2015: 273 citations2016: 281 citations2017: 408 citations2018: 277 citations2019: 1,037 citations2020: 1,225 citations2021: 1,285 citations2022: 1,000 citations2023: 774 citations2024: 1,174 citations2025: 535 citations2026: 22 citations1962–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1993: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,544 citing papers, 29.6% of this breakdownChina: 1,760 citing papers, 14.7% of this breakdownGermany: 760 citing papers, 6.3% of this breakdownUnited Kingdom: 531 citing papers, 4.4% of this breakdownItaly: 520 citing papers, 4.3% of this breakdownCanada: 405 citing papers, 3.4% of this breakdownFrance: 359 citing papers, 3% of this breakdownNetherlands: 345 citing papers, 2.9% of this breakdownJapan: 322 citing papers, 2.7% of this breakdownSwitzerland: 310 citing papers, 2.6% of this breakdownSouth Korea: 255 citing papers, 2.1% of this breakdownSpain: 252 citing papers, 2.1% of this breakdown
0%29.6%Other 21.9%

Institutions

Fields

  • Medicine53.3%
  • Biochemistry, Genetics and Molecular Biology30.5%
  • Immunology and Microbiology6.3%
  • Neuroscience5.6%
  • Engineering1.4%
  • Computer Science0.8%
  • Other2.1%

Topics

  • Glioma Diagnosis and Treatment16.2%
  • Immune cells in cancer3.5%
  • Brain Metastases and Treatment2.9%
  • MicroRNA in disease regulation2.9%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Cancer, Hypoxia, and Metabolism2.4%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

    Authors: Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins - Nature Medicine 2019 cited by 1,387

  2. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    Authors: Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta - New England Journal of Medicine 2014 cited by 2,793

  3. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

    Authors: Michele Ceccarelli, Floris P Barthel, Tathiane M. Malta, Thaís S. Sabedot, Sofie R. Salama, Bradley A. Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano Maria Pagnotta, Samreen Anjum, Jiguang Wang, Ganiraju C. Manyam, Pietro Zoppoli, Shiyun Ling, Arjun A. Rao, Mia Grifford, Andrew D. Cherniack, Hailei Zhang, Laila Poisson, Carlos Gilberto Carlotti, Daniela Pretti da Cunha Tirapelli, Arvind Rao, Tom Mikkelsen, Ching C. Lau, W. K. Alfred Yung, Raúl Rabadán, Jason T. Huse, Daniel J. Brat, Norman L. Lehman, Jill S. Barnholtz‐Sloan, Siyuan Zheng, Kenneth R. Hess, Ganesh Rao, Matthew Meyerson, Rameen Beroukhim, Lee Cooper, Rehan Akbani, Margaret Wrensch, David Haussler, Kenneth D. Aldape, Peter W. Laird, David H. Gutmann, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Samreen Anjum, Harindra Arachchi, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Gene H. Barnett, Stephen Baylin, Sue Bell, Christopher C. Benz, Natalie Bir, Keith L. Black, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Christopher A. Bristow, Yaron S.N. Butterfield, Qingrong Chen, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Simon G. Coetzee, Mark L. Cohen, Howard Colman, Marta Couce, Fulvio D’Angelo, Tanja M. Davidsen, Amy Davis, John A. Demchok, Karen Devine, Li Ding, Rebecca Duell, J. Bradley Elder, Jennifer Eschbacher, Ashley Fehrenbach, Martin L. Ferguson, Scott Frazer, Gregory N. Fuller, Jordonna Fulop, Stacey Gabriel, Luciano Garofano, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Caterina Giannini, William J. Gibson, Angela Hadjipanayis, D. Neil Hayes, David I. Heiman, Beth Hermes, Joe Hilty, Katherine A. Hoadley and 108 more - Cell 2016 cited by 2,375

  4. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Authors: Farshad Nassiri, Vikas Patil, Leeor Yefet, Olivia Singh, Jeff Liu, Rachel M. A. Dang, Takafumi N. Yamaguchi, Mariza Daras, Timothy F. Cloughesy, Howard Colman, Priya Kumthekar, Clark C. Chen, Robert Aiken, Morris D. Groves, Shirley Ong, Rohan Ramakrishna, Michael A. Vogelbaum, Simon Khagi, Thomas Kaley, Jason M. Melear, David M. Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh Nair, Vinay K. Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López‐Janeiro, Carlos E. de Andrea, Marta M. Alonso, Paul C. Boutros, Joan M. Robbins, Warren Mason, Adam M. Sonabend, Roger Stupp, Juàn Fueyo, Candelaria Gomez‐Manzano, Frederick F. Lang, Gelareh Zadeh - Nature Medicine 2023 cited by 270

  5. Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

    Authors: Krishna Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, Ravesanker Ezhilarasan, Karlijn Hummelink, Faith Hollingsworth, Khalida Wani, Lindsey Heathcock, Johanna D. James, Lindsey D. Goodman, Siobhan Conroy, Lihong Long, Nina Lelic, Suzhen Wang, Joy Gumin, Divya Raj, Yoshinori Kodama, Aditya Raghunathan, Adriana Olar, Kaushal Joshi, Christopher E. Pelloski, Amy B. Heimberger, Se Hoon Kim, Daniel P. Cahill, Ganesh Rao, Wilfred F.A. den Dunnen, Hendrikus Boddeke, Heidi Phillips, Ichiro Nakano, Frederick F. Lang, Howard Colman, Erik P. Sulman, Kenneth Aldape - Cancer Cell 2013 cited by 1,133

  6. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

    Authors: Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin Bloch, Matthew C. Tate, Margaret Schwartz, Laura Zuckerman, Ray Lezon, Rimas V. Lukas, Borko Jovanovic, Kathleen McCortney, Howard Colman, Si Chen, Barry Lai, Olga Antipova, Junjing Deng, Luxi Li, Serena Tommasini-Ghelfi, Lisa Hurley, Dusten Unruh, Nitya V. Sharma, Manoj Kandpal, Fotini M. Kouri, Ramana V. Davuluri, Daniel J. Brat, Miguel Muzzio, Mitchell Glass, Vinod Vijayakumar, Jeremy D. Heidel, Francis J. Giles, Ann K. Adams, C. David James, Gayle E. Woloschak, Craig Horbinski, Alexander H. Stegh - Science Translational Medicine 2021 cited by 318

  7. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Authors: Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados - Neuro-Oncology 2015 cited by 580

  8. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

    Authors: Heidi Phillips, Samir Kharbanda, Ruihuan Chen, William F. Forrest, Robert Soriano, Thomas D. Wu, Anjan Misra, Janice Nigro, Howard Colman, Liliana Soroceanu, P. Mickey Williams, Zora Modrušan, Burt G. Feuerstein, Ken Aldape - Cancer Cell 2006 cited by 3,180

  9. Glioma Subclassifications and Their Clinical Significance

    Authors: Ricky Chen, Matthew Smith-Cohn, Adam L. Cohen, Howard Colman - Neurotherapeutics 2017 cited by 858

  10. Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

    Authors: Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McCluskey, Sarah Gaffey, Timothy R. Smith, David J. Coté, Mariano Severgnini, Jennifer H. Yearley, Qing Zhao, Wendy M. Blumenschein, Dan G. Duda, Alona Muzikansky, Rakesh K. Jain, Patrick Y. Wen, David A. Reardon - Clinical Cancer Research 2020 cited by 257

  11. The transcriptional network for mesenchymal transformation of brain tumours

    Authors: Maria Stella Carro, Wei Keat Lim, Mariano J. Alvarez, Robert J. Bollo, Xudong Zhao, Evan Y. Snyder, Erik P. Sulman, Sandrine L. Anne, Fiona Doetsch, Howard Colman, Anna Lasorella, Ken Aldape, Andrea Califano, Antonio Iavarone - Nature 2009 cited by 1,311

  12. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Authors: Daniel J. Brat, Kenneth Aldape, Howard Colman, Eric C. Holland, David N. Louis, Robert B. Jenkins, Bette K. Kleinschmidt‐DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp, Andreas von Deimling, Michael Weller - Acta Neuropathologica 2018 cited by 906

  13. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

    Authors: Daniel J. Brat, Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N. Fuller, Caterina Giannini, Eric C. Holland, Robert B. Jenkins, Bette K. Kleinschmidt‐DeMasters, Takashi Komori, Johan M. Kros, David N. Louis, Catriona McLean, Arie Perry, Guido Reifenberger, Chitra Sarkar, Roger Stupp, Martin J. van den Bent, Andreas von Deimling, Michael Weller - Acta Neuropathologica 2020 cited by 530

  14. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

    Authors: Alicia Rivera, Christopher E. Pelloski, Mark R. Gilbert, Howard Colman, C. Cruz, Erik P. Sulman, B. Nebiyou Bekele, Kenneth Aldape - Neuro-Oncology 2009 cited by 454

  15. IDH1 and IDH2 Mutations in Gliomas

    Authors: Adam L. Cohen, Sheri L. Holmen, Howard Colman - Current Neurology and Neuroscience Reports 2013 cited by 624

  16. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial

    Authors: Macarena I. de la Fuente, Howard Colman, Mark Rosenthal, Brian Andrew Van Tine, Danijela Levacic, Tobias Walbert, Hui Gan, María Vieito, Mohammed Milhem, Kathryn Lipford, Sanjeev Forsyth, Sylvie M. Guichard, Yelena Mikhailov, Alexander Sedkov, Julie Brevard, Patrick Kelly, Hesham Mohamed, Varun Monga - Neuro-Oncology 2022 cited by 70

  17. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups

    Authors: Philipp Karschnia, Marion Smits, Guido Reifenberger, Émilie Le Rhun, Benjamin M. Ellingson, Norbert Galldiks, Michelle M. Kim, Jason T. Huse, Oliver Schnell, Patrick N. Harter, Malte Mohme, Kenneth Aldape, Joachim M. Baehring, Lorenzo Bello, Daniel J. Brat, Daniel P. Cahill, Caroline Chung, Howard Colman, Jörg Dietrich, Katharine J. Drummond, Yoshua Esquenazi, Elizabeth R. Gerstner, Julia Furtner, Valentina Garibotto, Timothy J. Kaufmann, Takashi Komori, Rupesh Kotecha, Linda M. Liau, Janine Lupo, Giuseppe Minniti, Yoshitaka Narita, Maximilian Niyazi, Arie Perry, Matthias Preusser, Roberta Rudà, Nader Sanai, Nils Ole Schmidt, Joachim P. Steinbach, Stefanie Thust, Nelleke Tolboom, Anouk van der Hoorn, Thijs van der Vaart, Antoine Verger, Einar Osland Vik-Mo, Colin Watts, Manfred Westphal, Pieter Wesseling, Jacob S. Young, Louisa von Baumgarten, Nathalie L. Albert, Raymond Y. Huang, Minesh P. Mehta, Martin J. van den Bent, Michael Weller, Michael A. Vogelbaum, Susan Chang, Mitchel S. Berger, J. C. Tonn - The Lancet Oncology 2023 cited by 60

  18. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

    Authors: Patrick Y. Wen, Mehdi Touat, Brian M. Alexander, Ingo K. Mellinghoff, Shakti Ramkissoon, Christine McCluskey, Kristine Pelton, Sam Haidar, Sankha S. Basu, Sarah Gaffey, Loreal Brown, Juan Emmanuel Martinez-Ledesma, Shaofang Wu, Jung-Woo Kim, Wei Wei, Mi‐Ae Park, Jason T. Huse, John G. Kuhn, Mikael L. Rinne, Howard Colman, Nathalie Y.R. Agar, Antonio Omuro, Lisa M. DeAngelis, Mark R. Gilbert, John de Groot, Timothy F. Cloughesy, Andrew Chi, Thomas M. Roberts, Jean J. Zhao, Eudocia Q. Lee, Lakshmi Nayak, James R. Heath, Laura L. Horky, Tracy T. Batchelor, Rameen Beroukhim, Susan M. Chang, Azra H. Ligon, Ian F. Dunn, Dimpy Koul, Geoffrey S. Young, Michael D. Prados, David A. Reardon, W.K. Alfred Yung, Keith L. Ligon - Journal of Clinical Oncology 2019 cited by 155

  19. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

    Authors: Kirit Singh, Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y. Wen, Giuseppe Minniti, Howard Colman, Timothy F. Cloughesy, Minesh P. Mehta, Marjolein Geurts, Isabel Arrillaga‐Romany, Annick Desjardins, Kirk Tanner, Susan Short, David Arons, Elizabeth S. Duke, Wolfgang Wick, Stephen Bagley, David M. Ashley, Priya Kumthekar, Roel G.W. Verhaak, Anthony J. Chalmers, Anoop P. Patel, Colin Watts, Peter E. Fecci, Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw - Nature Medicine 2023 cited by 53

  20. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

    Authors: Rifaquat Rahman, Lorenzo Trippa, Eudocia Q. Lee, Isabel Arrillaga‐Romany, Geoffrey Fell, Mehdi Touat, Christine McCluskey, Jennifer Wiley, Sarah Gaffey, Jan Drappatz, Mary Welch, Evanthia Galanis, Manmeet S. Ahluwalia, Howard Colman, Burt Nabors, Jaroslaw T. Hepel, Heinrich Elinzano, David Schiff, Ugonma Chukwueke, Rameen Beroukhim, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Tracy T. Batchelor, Mikael L. Rinne, Thomas Kaley, Christine Lu‐Emerson, Ingo K. Mellinghoff, Wenya Linda Bi, Omar Arnaout, Pierpaolo Peruzzi, Daphne A. Haas‐Kogan, Shyam Tanguturi, Daniel Cagney, Ayal A. Aizer, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, Jack Geduldig, Fiona Watkinson, William Pisano, Seth Malinowski, Shakti Ramkissoon, Sandro Santagata, David M. Meredith, E. Antonio Chiocca, David A. Reardon, Brian M. Alexander, Keith L. Ligon, Patrick Y. Wen - Journal of Clinical Oncology 2023 cited by 50

  21. FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis

    Authors: Nu Zhang, Ping Wei, Aihua Gong, Wen‐Tai Chiu, Hsueh‐Te Lee, Howard Colman, He Huang, Jianfei Xue, Mingguang Liu, Yong Wang, Raymond Sawaya, Keping Xie, W.K. Alfred Yung, René H. Medema, Xi He, Suyun Huang - Cancer Cell 2011 cited by 583

  22. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

    Authors: Aaron C. Tan, Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Wolfgang Wick, Susan M. Chang, Evanthia Galanis, Alireza Mansouri, Simon Khagi, Minesh P. Mehta, Amy B. Heimberger, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John Simes, Scott Antonia, Don Berry, Mustafa Khasraw - Journal for ImmunoTherapy of Cancer 2021 cited by 81

  23. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

    Authors: Krishna Bhat, Katrina L. Salazar, Veerakumar Balasubramaniyan, Khalida Wani, Lindsey Heathcock, Faith Hollingsworth, Johanna D. James, Joy Gumin, Kristin Diefes, Se Hoon Kim, Alice Turski, Yasaman Azodi, Yuhui Yang, Tiffany Doucette, Howard Colman, Erik P. Sulman, Frederick F. Lang, Ganesh Rao, Sjef Copray, Brian Vaillant, Kenneth Aldape - Genes & Development 2011 cited by 375

  24. Toward precision medicine in glioblastoma: the promise and the challenges

    Authors: Michael D. Prados, Sara A. Byron, Nhan L. Tran, Joanna J. Phillips, Annette M. Molinaro, Keith L. Ligon, Patrick Y. Wen, John G. Kuhn, Ingo K. Mellinghoff, John de Groot, Howard Colman, Timothy F. Cloughesy, Susan M. Chang, Timothy C. Ryken, Waibhav Tembe, Jeffrey Kiefer, Michael E. Berens, David W. Craig, John D. Carpten, Jeffrey M. Trent - Neuro-Oncology 2015 cited by 223